Rayner, Emma

A Susceptible Mouse Model for Zika Virus Infection

Dowall, S. D., Graham, V. A., Rayner, E., Atkinson, B., Hall, G., Watson, R. J., Bosworth, A., Bonney, L. C., Kitchen, S., & Hewson, R. (2016) · PLoS neglected tropical diseases

Mosquito-borne diseases and controlViral Infections and Vectors

Cited by 323

Non-Replicating Mycobacterium tuberculosis Elicits a Reduced Infectivity Profile with Corresponding Modifications to the Cell Wall and Extracellular Matrix

Bacon, J., Alderwick, L. J., Allnutt, J. A., Gabasova, E., Watson, R., Hatch, K. A., Clark, S. O., Jeeves, R. E., Marriott, A., Rayner, E., et al. (2014) · PLoS ONE

Tuberculosis Research and EpidemiologyMycobacterium research and diagnosis

Cited by 74

Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system

Bottai, D., Frigui, W., Clark, S., Rayner, E., Zelmer, A., Andreu, N., de Jonge, M. I., Bancroft, G. J., Williams, A., Brodin, P., et al. (2015) · Vaccine

Tuberculosis Research and EpidemiologyImmune responses and vaccinations

Cited by 60

mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection

Rauch, S., Gooch, K., Hall, Y., Salguero, F. J., Dennis, M. J., Gleeson, F. V., Harris, D., Ho, C., Humphries, H. E., Longet, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory)

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 48